Kips Bay Medical said in a regulatory filing that it plans to go public in hopes it will secure $57.5 million. The Plymouth, Minn.-based firm said it plans to use the proceeds from the initial public offering to conduct clinical studies in the U.S. and seek regulatory approval for a nitinol mesh sleeve used to back up a vein graft used in coronary artery bypass grafting surgery.

Related Summaries